Legend Biotech Corporation

NasdaqGS:LEGN Stock Report

Market Cap: US$6.3b

Legend Biotech Management

Management criteria checks 2/4

Legend Biotech's CEO is Ying Huang, appointed in Sep 2020, has a tenure of 4.25 years. directly owns 0.035% of the company’s shares, worth $2.19M. The average tenure of the management team and the board of directors is 2.6 years and 3.5 years respectively.

Key information

Ying Huang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.3yrs
CEO ownership0.04%
Management average tenure2.6yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

Legend Biotech: The Story Brightens

Dec 05

Legend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Nov 15
Legend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Legend Biotech: Entering Accelerated Growth Phase, Carvykti Positions Company For Valuation Expansion

Sep 18

Optimistic Investors Push Legend Biotech Corporation (NASDAQ:LEGN) Shares Up 26% But Growth Is Lacking

Aug 01
Optimistic Investors Push Legend Biotech Corporation (NASDAQ:LEGN) Shares Up 26% But Growth Is Lacking

Legend Biotech's Promising CAR-T Therapies Face Valuation And Cash Burn Challenges

Jul 30

Rock star Growth Puts Legend Biotech (NASDAQ:LEGN) In A Position To Use Debt

Jul 05
Rock star Growth Puts Legend Biotech (NASDAQ:LEGN) In A Position To Use Debt

Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances

May 14

Some Shareholders Feeling Restless Over Legend Biotech Corporation's (NASDAQ:LEGN) P/S Ratio

May 13
Some Shareholders Feeling Restless Over Legend Biotech Corporation's (NASDAQ:LEGN) P/S Ratio

Legend Biotech: AdCom Documents Shed Light On Carvykti's Problems (Downgrade)

Mar 15

Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?

Mar 06
Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?

Legend Biotech: Solid Traction With Carvykti Rollout

Jan 29

Legend Biotech Corporation's (NASDAQ:LEGN) Share Price Not Quite Adding Up

Jan 16
Legend Biotech Corporation's (NASDAQ:LEGN) Share Price Not Quite Adding Up

Legend Biotech wins approval of Carvykti for multiple myeloma in Japan

Sep 27

Legend Biotech stock slides on proposed ADS offering

Jul 25

Legend Biotech ends Phase 1 trial for lymphoma candidate

Jul 07

Legend Biotech: Carvykti Approval Makes For A Buy Opportunity

Mar 04

CEO

Ying Huang (51 yo)

4.3yrs

Tenure

Dr. Ying Huang, Ph D., is Chief Executive Officer of Legend Biotech Corporation since November 06, 2020 and serves as its Director since December 2021. He had been Chief Financial Officer of Legend Biotech...


Leadership Team

NamePositionTenureCompensationOwnership
Ying Huang
CEO & Director4.3yrsno data0.035%
$ 2.2m
Lori Macomber
Chief Financial Officer2.6yrsno data0.0031%
$ 191.9k
Doug Wallace
Vice President of Global Operations1.1yrsno datano data
Guowei Fang
Chief Scientific Officer & Head of Business Developmentno datano datano data
Joanne Choi
Senior Manager of Investor Relationsno datano datano data
James Pepin
General Counsel1.1yrsno datano data
Tim Roberts
Global Compliance Officerless than a yearno datano data
Deborah Wong
Executive Director of Strategic Marketing & Corporate Communicationsno datano datano data
Elaine Qian
VP & Global Head of Human Resources1.7yrsno datano data
Yuhong Qiu
Senior Vice President of Global Regulatory Affairs2.9yrsno datano data
Steven Gavel
Senior Vice President of Commercial Development2.9yrsno datano data
Alan Kick
Senior Vice President of Global Quality2.9yrsno datano data

2.6yrs

Average Tenure

Experienced Management: LEGN's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ying Huang
CEO & Director3yrsno data0.035%
$ 2.2m
John M. Maraganore
Member of Strategic Advisory Board1.7yrsno datano data
Li Zhu
Non-Independent Director4.1yrsno datano data
Corazon Sanders
Independent Director4.6yrsno data0.010%
$ 654.0k
Xiaohui Ji
Independent Director4.6yrsno data0.0050%
$ 313.9k
Tomas Heyman
Independent Director2.3yrsno data0.0011%
$ 69.4k
Fangliang Zhang
Independent Chairman2.3yrsno data0%
$ 0
Ye Wang
Director9.6yrsno data0%
$ 0
Michel Vounatsos
Member of Strategic Advisory Board1.7yrsno datano data
Wai Man Yau
Independent Director4.6yrsno data0.0010%
$ 63.8k
Patrick Casey
Independent Director4yrsno data0.0069%
$ 431.4k
Li Mao
Independent Director2.3yrsno data0.0019%
$ 118.2k

3.5yrs

Average Tenure

62yo

Average Age

Experienced Board: LEGN's board of directors are considered experienced (3.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 04:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Legend Biotech Corporation is covered by 27 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Huidong WangBarclays
Konstantinos BiliourisBMO Capital Markets Equity Research